Clinical Trial Update: Pharmacokinetics and Safety of Moxifloxacin [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the pharmacokinetics and safety of moxifloxacin for tuberculosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Tuberculosis | Phase 4 | Status: TERMINATED